BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Sep 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-05

Reporting Person: HERTIA JOHN (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-05	Bio-Rad A Common Stock	M	600	—	Acquired	15507	Direct
2019-09-05	Bio-Rad A Common Stock	F	208	$339.48	Disposed	15299	Direct
2019-09-06	Bio-Rad A Common Stock	M	2400	$119.54	Acquired	17699	Direct
2019-09-06	Bio-Rad A Common Stock	M	1800	$139.56	Acquired	19499	Direct
2019-09-06	Bio-Rad A Common Stock	M	1200	$159.32	Acquired	20699	Direct
2019-09-06	Bio-Rad A Common Stock	M	1200	$215.98	Acquired	21899	Direct
2019-09-06	Bio-Rad A Common Stock	M	600	$326.15	Acquired	22499	Direct
2019-09-06	Bio-Rad A Common Stock	S	700	$334.77	Disposed	21799	Direct
2019-09-06	Bio-Rad A Common Stock	S	1871	$335.64	Disposed	19928	Direct
2019-09-06	Bio-Rad A Common Stock	S	1231	$336.80	Disposed	18697	Direct
2019-09-06	Bio-Rad A Common Stock	S	750	$338.01	Disposed	17947	Direct
2019-09-06	Bio-Rad A Common Stock	S	543	$338.97	Disposed	17404	Direct
2019-09-06	Bio-Rad A Common Stock	S	100	$340.00	Disposed	17304	Direct
2019-09-07	Bio-Rad A Common Stock	M	600	—	Acquired	17904	Direct
2019-09-07	Bio-Rad A Common Stock	F	298	$335.59	Disposed	17606	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-05	Restricted Stock Units	$0	M	600	Disposed		Bio-Rad A Common Stock (600)	Direct
2019-09-06	Non-Qualified Stock Option (right to buy)	$119.54	M	2400	Disposed	2024-09-10	Bio-Rad A Common Stock (2400)	Direct
2019-09-06	Non-Qualified Stock Option (right to buy)	$139.56	M	1800	Disposed	2025-09-11	Bio-Rad A Common Stock (1800)	Direct
2019-09-06	Non-Qualified Stock Option (right to buy)	$159.32	M	1200	Disposed	2026-09-07	Bio-Rad A Common Stock (1200)	Direct
2019-09-06	Non-Qualified Stock Option (right to buy)	$215.98	M	1200	Disposed	2027-09-05	Bio-Rad A Common Stock (1200)	Direct
2019-09-06	Non-Qualified Stock Option (right to buy)	$326.15	M	600	Disposed	2028-09-04	Bio-Rad A Common Stock (600)	Direct
2019-09-07	Restricted Stock Units	$0	M	600	Disposed		Bio-Rad A Common Stock (600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	252	Indirect

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.29 to $335.22, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.32 to $336.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.36 to $337.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.63 to $338.44, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.63 to $339.17, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F8: The restricted stock units vest in five equal annual installments beginning September 5, 2018.

F9: The option vests in five equal annual installments beginning September 10, 2015.

F10: The option vests in five equal annual installments beginning September 11, 2016.

F11: The option vests in five equal annual installments beginning September 7, 2017.

F12: The option vests in five equal annual installments beginning September 5, 2018.

F13: The option vests in five equal annual installments beginning September 4, 2019.

F14: The restricted stock units vest in five equal annual installments beginning September 7, 2017.